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This Month in the Journal
This month in the Journal, Dominic Kwiatkowski dis-
cusses one of the strongest selective forces that has acted
on the human genome in recent times: malaria. One of
the striking things about this selection is that it has re-
sulted in several different resistance alleles that vary by
location, so that a common malaria-resistance allele in
Africa is rarely found in Southeast Asia, and vice versa.
Not only do genetic studies of malaria resistance tell us
something about humans, they also tell us about the life
cycle of the malarial parasites, and they have led to novel
approaches to malaria prevention.
Sotos Genotype-Phenotype Analyses, by Tatton-Brown
et al. (p. 193)
Mutations in NSD1—and chromosome 5q35 microdele-
tions that include NSD1—cause Sotos syndrome, which
is typically known as an overgrowth syndrome. It has
been speculated that the phenotypes of individuals with
mutations localized to NSD1 would differ from those
with microdeletions, but, since the phenotypic range for
these mutations hasn’t been defined, this speculation has
not yet been thoroughly examined. Tatton-Brown et al.
analyzed 530 individuals with a range of phenotypes and
found 266 cases that had defects at NSD1. The muta-
tion-positive cases were almost completely restricted to
those individuals given a clinical diagnosis of typical or
possible Sotos syndrome. This contrasts with previous
reports that suggested some cases of Weaver and Beck-
with-Wiedemann syndromes result from defects in NSD1.
Also in contrast to previous reports is the fact that Tat-
ton-Brown et al. ascribe the clinical features of 5q35
microdeletions to NSD1 haploinsufficiency and not to
other genes in the deleted interval. This large collection
of affected individuals allowed Tatton-Brown et al. to
better designate the cardinal features of Sotos syndrome,
which are facial dysmorphism, learning disabilities,
and childhood overgrowth. Although each is present in
190% of cases, the severity varies quite widely among
individuals. Perhaps surprisingly for what has been de-
fined an overgrowth syndrome, 10% of mutation-pos-
itive cases had growth within the normal range, so over-
growth is not a requirement for the diagnosis of Sotos
syndrome.
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Alleles at SLC6A4/SERT Confer Risk of Autism, by
Sutcliffe et al. (p. 265)
Linkage of autism near the serotonin transporter locus
SLC6A4 has been found in a few studies, and support
for this locus seems to be stronger in families that have
only affected males, which is interesting in light of the
fact that the affected male:female ratio for autism is ∼4:
1. Although SLC6A4 is a great candidate gene, the re-
sults of association studies of this locus have not been
strong enough to explain the linkage signal in this area.
Sutcliffe et al. reexamine the role of this locus in autism
through studies of rare variation in this gene. In a sample
in which they demonstrate highly significant linkage to
this region, they report coding substitutions in SLC6A4
that are associated with increased rigid-compulsive be-
haviors. In their linked families, the most common of
these substitutions, Gly56Ala, is at increased frequency
compared with previous reports in a control population.
Gly56Ala exhibits transmission distortion, and the en-
coded protein has an elevated basal activity and insen-
sitivity to certain stimuli. Sutcliffe et al. also found non-
coding variations that collectively show transmission dis-
equilibrium. They propose that multiple rare variants,
rather than common variants, in SLC6A4 confer sus-
ceptibility to autism-spectrum disorders and contribute
substantially to the linkage to this region.
CCD and Growth-Plate Abnormalities, by Zheng et al.
(p. 305)
Cleidocranial dysplasia (CCD) is a result of defective
ossification and is characterized by a persistently open
skull suture, short stature, dental anomalies, and hypo-
or aplastic clavicles. CCD is caused by mutations in
RUNX2, which encodes an osteoblast-specific transcrip-
tion factor, and is thought to be due to defects in intra-
membranous ossification and possibly endochondral os-
sification. Mouse models expressing various forms and
amounts of Runx2 have provided evidence that this tran-
scription factor is crucial for osteoblast differentiationand
subsequent bone-matrix deposition by the differentiated
osteoblasts, but mouse models could take researchers
only so far because of phenotypic differences between
RUNX2-deficient humans and mice. Zheng et al. char-
acterized the effects of a RUNX2 mutation in a rare
human sample, a 20-wk fetus with CCD. This single-
base insertion results in a 50% decrease in RUNX2
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mRNA in cartilage. Compared with an age-matched
control, growth-plate sections in the affected fetus were
disorganized and exhibited decreased chondrocyte hy-
pertrophy as well as altered expression of collagen X.
Zheng et al. also measured the expression of RUNX2
target genes and found reduced expression of genes that
are normally highly expressed in differentiated chondro-
cytes. This study supports the proposal that endochon-
dral ossification defects that are the result of altered
regulation of genes expressed in chondrocytes contribute
to the CCD phenotype.
French-Canadian LHON Due to Fille du Roy, by
Laberge et al. (p. 313)
In contrast to many other countries, the most prevalent
mutation that causes Leber hereditary optic neuropathy
(LHON) in the French Canadian population is T14484C.
Haplogroup analysis of this mtDNA mutation suggested
that its increased prevalence is due to a founder effect,
possibly from one woman. Laberge et al. investigated this
idea through use of Quebec’s genealogical records and
found that, of the 12 genealogies they could reconstruct
for LHON-affected individuals, 11 were related to the
same female founder through their maternal lineage.
Compared with simulations based on a sample of in-
dividuals who were geographically matched with the
cases, this level of maternal relatedness was highly sig-
nificant. The female founder who was identified was
born in France and was sent to Nouvelle-France in the
17th century as a “fille du roy,” or daughter of the King.
During that time, Louis XIV sent the filles du roy to
Nouvelle-France to improve the male:female ratio in the
colony. These single women, often wards of the state,
were supposed to marry in the colony, thereby promot-
ing permanent settlement. Laberge et al. traced the mi-
gration of the female descendents of this woman largely
to southwest Quebec, a location that corresponds quite
well with the current distribution of LHON cases due
to T14484C in French Canadians.
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